Akso Health Group

Akso Health Group(AHG)股票分析

$1.330

+0.031 (+2.31%)收盤時

Loading chart…
最高
1.370
開盤
1.300
成交量加權均價
1.33
成交量
33.07K
市值
112.36M
最低
1.280
成交金額
43.87K
企業價值/稅息折舊攤銷前利潤(TTM)
-35.26

Akso Health Group is a holding company mainly engaged in marketing promotion services and sales of medical devices. The marketing promotion services business is principally engaged in the provision of marketing promotion services to car insurance broker industry. The sales of medical devices business is mainly engaged in the sale of medical devices such as defibrillators and anesthesia laryngoscope. The Company also provides radiotherapy (RT), personalized consultation, conventional treatment planning, and other related services for a wide variety of cancer therapy treatments, as well as online healthcare services, including health consultancy services and online sales of medicines and health products through the online health product marketplace.

AI 分析 of Akso Health Group (AHG)

持有

Currently, Akso Health Group (AHG) is not a strong buy. The stock is trading at $1.30, which is significantly below its 200-day simple moving average of $1.516, indicating a bearish trend. Additionally, the stock has a negative forward P/E ratio of 0, suggesting uncertainty about future earnings. While the RSI is at 58.02, indicating potential for upward momentum, the recent 5-day change is -3.70%, reflecting short-term weakness. The main risk is the stock's high price-to-sales ratio of 75.56, which indicates it may be overvalued compared to its sales performance.

估值指標

Akso Health Group(AHG)目前預期本益比為 0.00,5 年平均預期本益比為 0.44。

預期本益比

低估
5 年均值 P/E
0.44
目前P/E
0.00
高估
0.68
低估
0.20

預期 EV/EBITDA

低估
5 年均值 EV/EBITDA
-8.16
目前EV/EBITDA
-35.26
高估
13.41
低估
-29.72

預期股價營收比

高估
5 年均值 P/S
3.75
目前P/S
12.21
高估
8.68
低估
-1.18

Alphio AI 對 AHG 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%AHG

$2.52

情境價格

基

基準

基準 · 50%AHG

$2.26

情境價格

悲

悲觀

悲觀 · 25%AHG

$2.01

情境價格

AHG 常見問題 —— 由 Alphio AI 解答

Akso Health Group is a holding company mainly engaged in marketing promotion services and sales of medical devices. The marketing promotion services business is principally engaged in the provision of marketing promotion services to car insurance broker industry. The sales of medical devices business is mainly engaged in the sale of medical devices such as defibrillators and anesthesia laryngoscope. The Company also provides radiotherapy (RT), personalized consultation, conventional treatment planning, and other related services for a wide variety of cancer therapy treatments, as well as online healthcare services, including health consultancy services and online sales of medicines and health products through the online health product marketplace. It operates in the Technology sector (BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED industry).

Currently, Akso Health Group (AHG) is not a strong buy. The stock is trading at $1.30, which is significantly below its 200-day simple moving average of $1.516, indicating a bearish trend. Additionally, the stock has a negative forward P/E ratio of 0, suggesting uncertainty about future earnings. While the RSI is at 58.02, indicating potential for upward momentum, the recent 5-day change is -3.70%, reflecting short-term weakness. The main risk is the stock's high price-to-sales ratio of 75.56, which indicates it may be overvalued compared to its sales performance.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易